Dear Doctor,

Radioligand therapy (RLT) is becoming an important pillar of cancer care globally. To meet the need for widespread patient access to this therapy, there is a need to attract younger physicians to this area of medicine. Further, patient access in Switzerland will only be secured through strong multidisciplinary collaboration between oncologists and nuclear medicine physicians keeping up with the rapidly evolving clinical science. The objective of this event is therefore to train and connect young oncologists and nuclear medicine physicians interested in making RLT an essential pillar of oncology treatment.

Come and help us shape the future of cancer care in Switzerland!

We look forward to your attendance.

Date: November 27th, 2026

Time: 14:00 – 19:00 h

Place: Sitem-Insel

Credits: 5 SGNM/SSMN

3 Travel Awards for Oncologists and Nuclear Medicine Physicians - Apply now!

This year we will be awarding three travel awards to attend the ASCO, ESMO and EANM conferences:

· ASCO 2026, May 29 – June 2, Chicago, USA - Nuclear Medicine travel award

· EANM 2026, October 17-21, Vienna, Austria - Nuclear Medicine travel award

· ESMO 2026, October 23-27, Madrid, Spain - Oncology travel award

What can you expect from the award?

  • Mentorship

  • Travel, accommodation and registration fees*

*while adhering to 33% co-payment rule as outlined in Swiss Ordinance VITH

You must fulfill at least 2 of the following criteria:

  • Have an oncology or nuclear medicine FMH title

  • Be an experienced speaker involved in previous events

  • Have published research in RLT/GU oncology/nuclear medicine

  • Have been an investigator on clinical trials

  • Have treated a significant number of patients with RLT

  • Have been involved in local/international guidelines

  • Are a board member of a medical society

Apply by April 17th

Send your CV, motivation letter & letter of recommendation to gabriela.fosado_wyhooge@novartis.com. The steering committee will select the winners based on academic standing (i.e. the criteria listed above). Applicants should be in residency or have completed their FMH title in the last 5 yrs from the application deadline. Travel award winners will have the privilege of presenting their highlights of ASCO/ESMO/EANM at this event under the mentorship of Prof Schaefer.

Steering Committee

Valentina Garibotto

Prof Dr

HUG, Geneva

Magdalena Kulgawczuk

Dr

Inselspital, Bern

Aurelius Omlin

PD Dr

Onkozentrum, Zürich

Niklaus Schaefer

Prof Dr

CHUV, Lausanne

Michael Wissmeyer

PD Dr

Bürgerspital Solothurn

Anja Lorch

Prof Dr

USZ, Zürich

Schedule

-

Welcome & Introduction

Chairs: Drs Omlin & Schaefer

-

ASCO highlights (20 + 10 min)

Nucl Med - TBD

-

ESMO highlights (20 + 10 min)

Oncologist - TBD

-

EANM highlights (20 + 10 min)

Nucl Med - TBD

-

-------- Networking time ---------

Chair: Dr Wissmeyer

-

Workshop – Case discussions

3 cases @ 30 min (NM/Onc)

NM & Onco Case 1

NM & Onco Case 2

NM & Onco Case 3

-

-------- Networking time ---------

Chairs: Drs Lorch & Garibotto

-

Swiss PSMA PET/RLT Guidelines: An Update

Dr Burger, KSB/USZ/ETH

-

Swiss National RLT Stakeholder Initiative: An Update

Dr Schaefer, CHUV

-

--- Closing followed by Apero --

Auditorium sitem-insel - O2.211

sitem-insel

3010 Bern, Switzerland
3010 Bern

Registration